Summary
MORE than 1,000 patients with advanced cancer of the pancreas have begun a major trial of a vaccine which could lengthen the lives of sufferers.
The final stage of the TeloVac trial, taking place in 53 UK hospitals, is testing an injection which "primes" the body's immune system to recognise and kill cancer cells. Medics hope the therapy, which uses a vaccine called GV1001, will make chemotherapy more effective.See the full content of this document
Extract
; Worldtoday
Around 7,...
See the full content of this document
Sponsored links
